One of the missions of NewG Lab Pharma
(NGLP) will be to develop novel anticancer
therapeutics that extend the life of cancer patients
without compromising the quality of life.
As of May 1, 2020, NewG Lab Pharma received a letter from the FDA for Orphan drug designation (ODD)... |
As of April 24, 2020, NewG Lab Pharma received the status of Orphan Drug Designation (ODD) for liver... |
NewG Lab Pharma, a 100% U.S. subsidiary of New G Lab, announced on February 14, 2020, that it has si... |
Seminars with Georgia Medical ProfessionalsNovember 9, 2019 |
Seminars about Anti- Bacteria Treatment using 3BP with the University of Wroclaw, Poland.November... |